SCHEMBL6401331

SCHEMBL6401331

CC1COCC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21761910 1.00
SCHEMBL18124978 1.00
SCHEMBL11456306 0.74
SCHEMBL24477927 0.72
SCHEMBL18124976 0.72
SCHEMBL18124979 0.72
SCHEMBL16472422 0.72
SCHEMBL13799460 0.72
SCHEMBL14169716 0.72
SCHEMBL4269786 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4851163-A THIN BIOCIDAL LAYER ON POROUS CERAMIC BODY; BUBBLE DIFFUSERS THE REFRACTION CORPORATION (US) 1989-07-25 US claimed
WO-2022109182-A9 POLYHETEROCYCLIC GLP-1 R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2022-12-08 WO disclosed
WO-2022109182-A1 POLYHETEROCYCLIC GLP-1 R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2022-05-27 WO disclosed
CN-112574221-B Tetracyclic pyrimidinone compounds, preparation method, composition and application thereof 上海纽思克生物科技有限公司 2022-03-04 CN disclosed
EP-3825312-A1 INTERMEDIATES FOR PREPARING INHIBITORS OF HEPATITIS C VIRUS Gilead Pharmasset LLC (US) 2021-05-26 EP disclosed
EP-3492464-A1 INTERMEDIATES FOR PREPARING INHIBITORS OF HEPATITIS C VIRUS Gilead Sciences, Inc. (US) 2019-06-05 EP disclosed
EP-3466490-A1 POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE Gilead Sciences, Inc. (US) 2019-04-10 EP disclosed
EP-3277691-B1 POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE GILEAD SCIENCES INC (US) 2019-01-30 EP disclosed
US-20170290827-A1 INHIBITORS OF HEPATITIS C VIRUS GILEAD PHARMASSET LLC 2017-10-12 US disclosed
US-9655944-B2 Inhibitors of hepatitis C virus GILEAD SCIENCES, INC. (US) 2017-05-23 US disclosed
US-20150175655-A1 INHIBITORS OF HEPATITIS C VIRUS GILEAD PHARMASSET LLC 2015-06-25 US disclosed
US-8946205-B2 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors Janssen Pharmaceuticals, Inc. (US) 2015-02-03 US disclosed
US-20140017198-A1 INHIBITORS OF HEPATITIS C VIRUS GILEAD PHARMASSET LLC 2014-01-16 US disclosed
WO-2014008285-A1 INHIBITORS OF HEPATITIS C VIRUS GILEAD SCIENCES, INC. (US) 2014-01-09 WO disclosed
US-20090253881-A1 POLYMERIZABLE COMPOUND FOR PHOTORESIST, POLYMER THEREOF, AND PHOTORESIST COMPOSITION CONTAINING SUCH POLYMER IDEMITSU KOSAN CO., LTD. (JP) 2009-10-08 US disclosed
US-6924016-B2 Assembly system for stationing semiconductor wafer suitable for processing and process for manufacturing semiconductor wafer AZ ELECTRONIC MATERIALS USA CORP. (US) 2005-08-02 US disclosed
US-20030190446-A1 Assembly system for stationing semiconductor wafer suitable for processing and process for manufacturing semiconductor wafer MERCK PATENT GMBH (DE) 2003-10-09 US disclosed
EP-0372158-A1 Biofouling resistant apparatus for wastewater treatment REFRACTRON TECHNOLOGIES CORPORATION (US) 1990-06-13 EP disclosed
US-4676989-A Sweetening with cycloalkyl ethers and thioethers of dipeptides GENERAL FOODS CORPORATION (US) 1987-06-30 US disclosed
US-4638071-A ARTIFICIAL SWEETENERS GENERAL FOODS CORPORATION (US) 1987-01-20 US disclosed